
12R-LOX-IN-2
CAS No. 3026677-37-9
12R-LOX-IN-2( —— )
Catalog No. M37042 CAS No. 3026677-37-9
12R-LOX-IN-2 is an inhibitor of 12R-lipoxygenase (12R-LOX).12R-LOX-IN-2 inhibits imiquimod (IMQ)-induced hyperproliferation of psoriatic keratinocytes and inhibits colony formation.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 38 | Get Quote |
![]() ![]() |
10MG | 61 | Get Quote |
![]() ![]() |
25MG | 119 | Get Quote |
![]() ![]() |
50MG | 182 | Get Quote |
![]() ![]() |
100MG | 295 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product Name12R-LOX-IN-2
-
NoteResearch use only, not for human use.
-
Brief Description12R-LOX-IN-2 is an inhibitor of 12R-lipoxygenase (12R-LOX).12R-LOX-IN-2 inhibits imiquimod (IMQ)-induced hyperproliferation of psoriatic keratinocytes and inhibits colony formation.
-
Description12R-LOX-IN-2 is an inhibitor of 12R-lipoxygenase (12R-LOX).12R-LOX-IN-2 inhibits imiquimod (IMQ)-induced hyperproliferation of psoriatic keratinocytes and inhibits colony formation.12R-LOX-IN-2 also decreases the protein level of Ki67 and the mRNA expression of IL-17A in IMQ-induced cells. 12R-LOX-IN-2 may be useful in the study of psoriasis and other skin-associated inflammatory diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetLipoxygenase
-
RecptorLipoxygenase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3026677-37-9
-
Formula Weight271.31
-
Molecular FormulaC19H13NO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC=1C=CC(C2=NC=3C=CC=CC3C=C2)=C4C=CC=CC14
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
2-TEDC
2-TEDC is a potent lipoxygenase (LOX) inhibitor with inhibitory effects on 5-LOX, 12-LOX, and 15-LOX with IC50 values of 0.09 μM, 0.013 μM, and 0.5 μM, respectively.
-
L 651896
L 651896 is a novel leukotriene biosynthesis and 5-lipoxygenase inhibitor for the study of respiratory and cardiovascular diseases.
-
11-Keto-beta-boswell...
11-Keto-beta-boswellic acid, a novel Nrf2 activator, and a selective 5-lipoxygenase (5-LOX) inhibitor.